Product Overview
【Drug Name】
Generic Name: Compound Amino-polypeptide Tablets
Trade Name: Dansheng Zhiyinling
English Name: Compound Amino-polypeptide Tablets
Pinyin: Fufang Antaisu Pian
【Ingredients】
This product is a compound preparation. Each tablet contains 0.2g of amino-polypeptide, 0.02g of aminophylline, and 0.0005g of chlorpheniramine maleate.
【Appearance】
This product is a film-coated tablet, yellowish-brown after removing the coating.
【Indications】
Used for psoriasis.
【Dosage and Administration】
Oral administration. 2 tablets each time, 3 times a day. Reduce dosage for children or as directed by a physician. The onset of action is 1-2 weeks, and most patients show significant efficacy after 6-8 weeks of use.
【Adverse Reactions】
No adverse reactions have been reported.
【Contraindications】
Contraindicated in patients with known hypersensitivity to this product.
【Precautions】
Do not drive, operate dangerous machinery, or work at heights while taking this medication.
【Special Populations Use】
Children's Precautions: No such experiment has been conducted and there are no reliable references.
Pregnancy and Lactation Precautions: Not yet clear.
Elderly Precautions: No such experiment has been conducted and there are no reliable references.
【Drug Interactions】
Drug interactions may occur if used concurrently with other medications. Please consult your doctor or pharmacist for details.
【Pharmacological Actions】
This product can significantly improve human immunity, improve microcirculation, reduce blood viscosity, maintain normal human protein metabolism and the balance of various trace elements, and effectively regulate the proliferation and differentiation of human epidermal keratinocytes, thus playing a multifaceted role in eliminating psoriasis symptoms.
【Storage】
Store in a cool, dry place, protected from light and sealed.
【Specifications】
Compound
【Packaging Specifications】
120 tablets/box
【Shelf Life】
24 months
【Approval Number】
National Drug Approval Number H21023168
【Manufacturer】
Liaoning Dansheng Biopharmaceutical Co., Ltd.